The aim of SENS-501 (OTOF-GT) is to restore hearing by introducing a functional copy of the OTOF gene directly into hair cells via viral vector technology (AAV). This therapy aims to restore the ...
Technological Advancements : Ongoing innovations in gene delivery methods, such as the development of next-generation viral and non-viral vectors, are expected to drive substantial growth in the gene ...
Wilson is also the Chairperson of Franklin Biolabs, a Contract Research Organization that provides a full range of services from discovery to clinical vector manufacturing to the global genetic ...